One Shot (IMAGE)
Caption
As part of the clinical trial, researchers gave participants with a single dose of 3BNC117, a so-called broadly neutralizing antibody capable of fighting a wide range of HIV strains.
Credit
The Rockefeller University
Usage Restrictions
Image may be used only to illustrate the research described in the accompanying release.
License
Licensed content